[Therapy of arterial hypotension].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001285:Atropine / Q000627:therapeutic use; D002648:Child; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007022:Hypotension / Q000503:physiopathology / Q000628:therapy*; D007024:Hypotension, Orthostatic / Q000628:therapy; D007049:Iatrogenic Disease; D008297:Male; D008875:Middle Aged; D008901:Mineralocorticoids / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D013566:Sympathomimetics / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004876:Ergot Alkaloids; D008901:Mineralocorticoids; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D001285:Atropine
Die Therapie der arteriellen Hypotonie